News

Pfizer and BioNTech SE announced an advance purchase agreement with COVAX for up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine. The doses will be delivered throughout 2021. COVAX is a global initiative coordinated by the Global Alliance for...

Ubiquigent Limited (Ubiquigent) and the Mottram Laboratory at the University of York announced a collaboration to investigate the inhibition of deubiquitylase (DUB) enzymes expressed by the protozoan Leishmania mexicana for the treatment of leishmaniasis. The collaboration will be supported...

Pelican BioThermal, the global name in temperature controlled packaging, announces its latest partnership with Asiana Airlines, which will see an extensive expansion of the company’s growing global network. In the ongoing rapid response to support the global fight against COVID-19,...

Enara and Boehringer Ingelheim have teamed up to discover and develop novel cancer immunotherapies against overlooked dark antigen targets. How could dark antigens improve the treatment of solid tumour cancers. UK-based Enara Bio has entered into a collaboration with German-headquartered...

Indian drug regulator CDSCO’s subject expert committee has recommended granting permission for conducting Phase I clinical trial of Bharat Biotech’s intranasal Covid-19 vaccine (BBV154). Preclinical testing of the intranasal vaccine for toxicology, immunogenicity and challenge studies carried out in the...

Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of advanced assay development and laboratory testing services in the infectious, oncologic, and metabolic diseases fields, has signed an asset purchase agreement with GSK to acquire its...

Eli Lilly’s oncology-focused Loxo Oncology at Lilly will partner with Merus to develop up to three CD3-engaging T-cell re-directing bispecific antibody therapies, through a research collaboration and exclusive licensing agreement that could generate up to $1.6 billion for the...